COLLIER ALAN BRIAN (CEO) purchased 0.2% of their position (62K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $698.40 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+15K
Price / share
$0.01
Trade value
$177.00
% of position
Common Stock
Shares
+10K
Price / share
$0.01
Trade value
$118.00
% of position
Common Stock
Shares
+12K
Price / share
$0.01
Trade value
$139.20
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$22.80
% of position
Common Stock
Shares
+15K
Price / share
$0.01
Trade value
$159.00
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$21.20
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$20.40
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$20.40
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$20.40
% of position
Net shares
+62K
Net value
$698.40
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/25/2019 | P · Purchase | +15K | $0.01 | $177.00 | 0.1% | 24.86M | 24.87M |
| Common Stock Direct | 7/25/2019 | P · Purchase | +10K | $0.01 | $118.00 | 0.0% | 24.87M | 24.88M |
| Common Stock Direct | 7/26/2019 | P · Purchase | +12K | $0.01 | $139.20 | 0.0% | 24.88M | 24.90M |
| Common Stock Direct | 7/31/2019 | P · Purchase | +2K | $0.01 | $22.80 | 0.0% | 24.90M | 24.90M |
| Common Stock Direct | 8/7/2019 | P · Purchase | +15K | $0.01 | $159.00 | 0.1% | 24.90M | 24.91M |
| Common Stock Direct | 8/7/2019 | P · Purchase | +2K | $0.01 | $21.20 | 0.0% | 24.91M | 24.91M |
| Common Stock Direct | 8/7/2019 | P · Purchase | +2K | $0.01 | $20.40 | 0.0% | 24.91M | 24.92M |
| Common Stock Direct | 8/7/2019 | P · Purchase | +2K | $0.01 | $20.40 | 0.0% | 24.92M | 24.92M |
| Common Stock Direct | 8/7/2019 | P · Purchase | +2K | $0.01 | $20.40 | 0.0% | 24.92M | 24.92M |
| Total | +62K | $698.40 | ||||||